Biomimetic-Structured Cobalt Nanocatalyst Suppresses Aortic Dissection Progression by Catalytic Antioxidation

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Research

Background:

• Aortic dissection (AD) is a lethal cardiovascular disease often initiated by excessive reactive oxygen species (ROS).
• Current AD treatments lack efficient ROS scavenging capabilities, leading to poor therapeutic outcomes.
• Oxidative stress and inflammation in the aorta are key contributors to AD progression.

Purpose of the Study:

• To develop a novel nanocatalytic antioxidation strategy for treating aortic dissection.
• To investigate a biomimetic cobalt nanocatalyst for efficient and sustainable ROS scavenging.
• To explore the therapeutic potential of nanocatalysis in mitigating AD-associated vascular damage.

Main Methods:

• Construction of a cobalt nanocatalyst with a biomimetic structure.
• Utilizing theoretical calculations to elucidate the nanocatalytic antioxidation mechanism.
• Assessing the nanocatalyst's efficacy in scavenging ROS and modulating the aortic inflammatory microenvironment.
• Evaluating the impact on macrophage phenotype transition and vascular smooth muscle cell protection.

Main Results:

• The biomimetic cobalt nanocatalyst efficiently scavenges pathological ROS via a catalytic cycle involving cobalt redox transitions.
• Nanocatalytic antioxidation effectively alleviates oxidative stress in the AD region.
• The treatment modulates the aortic inflammatory microenvironment by promoting beneficial macrophage polarization.
• Vascular smooth muscle cells are protected from inflammation, leading to suppressed AD progression.

Conclusions:

• A nanocatalytic antioxidation approach using a biomimetic cobalt catalyst shows high therapeutic efficacy for AD.
• This strategy effectively reduces oxidative stress and vascular inflammation, key factors in AD.
• The findings present a promising new avenue for treating aortic dissection and other cardiovascular diseases.